Latest Risk Disclosure News

AuMEGA Metals Limited has launched a prospectus for a dual-tranche capital raising totalling approximately C$23.7 million, subject to shareholder approval, aimed at advancing its exploration programs in Newfoundland and Labrador, Canada.

Oneview Healthcare PLC has launched a Security Purchase Plan (SPP) to raise up to A$2 million, following a recent A$19 million placement. The SPP offers eligible shareholders discounted shares to support AI development and customer deployments.

AuMEGA Metals has announced a C$5.35 million capital raising via a flow-through unit offer aimed at advancing its exploration projects in Newfoundland and Labrador. The offer includes shares and warrants, targeting Canadian charity investors with tax incentives.

Gryphon Capital Income Trust (ASX:GCI) has announced a $90.9 million wholesale placement of new units priced at $2.00 each, aiming to bolster its portfolio management capabilities. The placement leverages existing capacity, avoiding the need for unitholder approval.

Verity Resources Limited has announced a pro-rata entitlement issue to raise up to $2.05 million, partially underwritten by entities linked to its directors. The capital raise aims to fund exploration and technical studies across its key projects, including the Monument Gold Project.

Commonwealth Bank of Australia’s latest Basel III Pillar 3 disclosures reveal steady capital adequacy ratios and proactive adaptation to evolving regulatory standards as of December 2025.

Talga Group has lodged a detailed prospectus for issuing attaching and piggyback options to recent Placement and Share Purchase Plan participants, potentially raising up to A$32.7 million upon exercise. The move supports its battery anode production scale-up and international expansion plans.

New Age Exploration Limited has issued a prospectus to facilitate secondary trading of new options issued under a recent $3.75 million placement, offering 1,000 new options at $0.01 each. The move aims to remove trading restrictions and improve liquidity for option holders.

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Cann Group Limited has launched a comprehensive suite of option offers aimed at raising incremental capital, subject to shareholder approval at a December 23 meeting. The prospectus outlines potential dilution and financial impacts as the company seeks to strengthen its balance sheet.

Equus Energy Limited launches a $15 million public offer to fund the acquisition and development of the Equus Gas Project in Western Australia, backed by conditional funding from Alcoa. The project boasts a large independently certified contingent gas resource, positioning the company to address looming supply shortfalls in domestic and LNG markets.

Xstate Resources has launched a prospectus offering nearly 97 million free attaching options to placement participants and contractors, alongside a nominal cleansing offer to remove trading restrictions on recent share issuances.